ArticleExperimental and therapeutic medicine2018

Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway.

Jing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.